I'm working on
4 months ago
Gene therapy, nucleic acid therapeutics, pulmonary delivery
About
Focus on nonviral vectors for nucleic acid therapeutics: engineering nanoparticles and polymer/peptide carriers for mRNA/DNA, optimizing magnetic and aerosol lung targeting, and characterizing airway biofluid interactions to improve transfection and translation to respiratory therapies.
Partnering listings
Learn more
Sign up to view the full profile.
Explore areas of focus, current work, and collaboration capabilities.Already have an account? Sign in
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.